Awareness of age-related macular degeneration in adults: The results of a large-scale international survey

Optometry

Volumn 74, Issue 1, 2003, Pages 16-24

  Rosenthal, Bruce ^a,b,d   Thompson, Bob ^c  

^a AMD Alliance International   (United States)

^b Jewish Guild for the Blind   (United States)

^c Macular Disease Society   (United Kingdom)

^d Lighthouse International   (United States)

Author keywords

Age related macular degeneration; Awareness; Eye examination; International survey; Legal blindness; Low vision; Vision impairment

Indexed keywords

ADULT; ATTITUDE; AWARENESS; DATA ANALYSIS; HEALTH SURVEY; HUMAN; INTERVIEW; MEDICAL INFORMATICS; PATIENT ATTITUDE; PERCEPTION; QUESTIONNAIRE; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; VISUAL IMPAIRMENT; ADOLESCENT; AGED; ARTICLE; ATTITUDE TO HEALTH; FEMALE; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; RETINA MACULA DEGENERATION;

ADOLESCENT; ADULT; AGED; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERNATIONAL COOPERATION; MACULAR DEGENERATION; MALE; MIDDLE AGED; QUESTIONNAIRES;

EID: 0037268084     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. World Health Organization. Measuring health. In: The World Health Report 1998 - Life in the 21st century: a vision for all. Geneva: World Health Organization, 1998:39-60.
2. Rosenthal B and Kelly K. Living well with macular degeneration: practical tips and essential information, 1st ed. New York: New American Library, 2001.
3. Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol 1988;32:375-413.
4. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study. I. Outline and major prevalence findings. Am J Epidemiol 1977;106:17-32.
5. Ferris FL III, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 1984;102:1640-2.
6. Age-related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report No. 8. Arch Ophthalmol 2001;119: 1417-36.
7. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1991;109:1220-31.
8. Macular Photocoagulation Study Group. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Arch Ophthalmol 1994;112:500-9.
9. Margherio RR, Margherio AR, DeSantis ME. Laser treatments with verteporfin therapy and its potential impact on retinal practices. Retina 2000;20:325-30.
10. Bressler NM. Early detection and treatment of neovascular age-related macular degeneration. J Am Board Fam Pract 2002;15:142-52.
11. Livingston PM, McCarty CA, Taylor HR. Knowledge, attitudes, and self care practices associated with age related eye disease in Australia. Br J Ophthalmol 1998;82:780-5.
12. Attebo K, Mitchell P, Cumming R, et al. Knowledge and beliefs about common eye diseases. Aust N Z J Ophthalmol 1997;25:283-7.
13. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Arch Ophthalmol 1991;109:1109-14.
14. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1990;108:816-24.
15. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration: guidelines for evaluation and treatment in the Macular Photocoagulation Study. Arch Ophthalmol 1991;109:1242-57.
16. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials - TAP Report 2. Arch Ophthalmol 2001;119:198-207.
17. Verteporfin In Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin In Photodynamic Therapy Report 2. Am J Ophthalmol 2001;131:541-60.
18. Rubin GS. Vision rehabilitation for patients with age-related macular degeneration. Eye 2001;15:430-5.
19. Livingston PM, Lee SE, De Paola C, et al. Knowledge of glaucoma, and its relationship to self-care practices, in a population sample. Aust N Z J Ophthalmol 1995;23:37-41.